The next board meeting for Compass Therapeutics Inc is on 09 Sep 2025 for the purpose of Morgan Stanley 23(rd) Annual Global Healthcare ConferenceSee details
Compass Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of 791.8%, and profit growth estimate of -55.4% for FY26, based on top 10 analyst calls.